Last reviewed · How we verify

SESAME OIL — Competitive Intelligence Brief

SESAME OIL (SESAME OIL) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D [EPC].

marketed Vitamin D [EPC] Live · refreshed every 30 min

Target snapshot

SESAME OIL (SESAME OIL).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SESAME OIL TARGET SESAME OIL marketed Vitamin D [EPC]
SODIUM ASCORBATE SODIUM ASCORBATE marketed Vitamin D [EPC] 2006-01-01
Infuvite Adult Colecalciferol Novartis marketed Vitamin D Vitamin D3 receptor 2000-01-01
Hectorol DOXERCALCIFEROL Sanofi marketed Vitamin D2 Analog [EPC] Vitamin D3 receptor 1999-01-01
Zemplar PARICALCITOL AbbVie marketed Vitamin D2 Analog [EPC] Vitamin D3 receptor 1998-01-01
Fosamax ALENDRONIC ACID Merck And Co Inc marketed Vitamin D [EPC] Farnesyl pyrophosphate synthase 1995-01-01
Dovonex CALCIPOTRIENE marketed Vitamin D Analog [EPC] Vitamin D3 receptor 1993-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Vitamin D [EPC] class)

  1. · 2 drugs in this class
  2. Abramson Cancer Center at Penn Medicine · 1 drug in this class
  3. Eli Lilly · 1 drug in this class
  4. Heather Wakelee · 1 drug in this class
  5. Merck And Co Inc · 1 drug in this class
  6. Mohammed Milhem, MBBS · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SESAME OIL — Competitive Intelligence Brief. https://druglandscape.com/ci/sesame-oil. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: